Patent · US Active

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

US9371318B2 · kind B2 · utility

1Cited by

3References

19Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Fabio Rancati · Parma, IT
Ian Linney · London, GB

Key dates

Filing date	Jan 23, 2015
Grant date	Jun 21, 2016
Priority date	—
Expiry date	Jan 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D215/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) described herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.